Anita Gashi is Chief Executive Officer of AdJane. She joined AdJane at its inception and has since shaped its strategy, team, and partnerships, building the organization around a vaccine platform originating from leading Dutch public research. She brings over a decade of experience commercializing technology platforms for pharmaceutical and vaccine R&D, partnering with global pharma and biotech organizations to address complex development challenges, with program implementations at AstraZeneca, Gilead, Roche and the US FDA, among others. Her background spans business development and strategic partnering across the life sciences, from early-stage technologies to clinical-stage assets. Throughout her career, she has worked at the interface of science and business, translating complex technologies into commercial and clinical value.